They found that by modifying METTL3 with small ubiquitin-like modifier 1 (SUMO1), the m6A level was reduced on mRNAs, which eventually contributed to the progression of NSCLC (84). The gene discussed is SUMO1; the disease is non-small cell lung carcinoma.